Physician profile
Ashley Rivers
NPI 1245398429
$11,848.99
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,425 · 2020: $2,036 · 2021: $355 · 2022: $12.79 · 2024: $19.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $4,678.58 | 2019-2020 | |
| Cardiovascular Systems INC. | $1,449.99 | 2019 | |
| Boston Scientific Corporation | $1,226.60 | 2019-2020 | |
| Terumo Medical Corporation | $1,191.95 | 2019-2020 | |
| Philips North America LLC | $1,101.52 | 2019-2021 | |
| Penumbra, INC. | $385.88 | 2019-2020 | |
| Abiomed | $333.32 | 2019-2020 | |
| Medtronic, INC. | $271.33 | 2021 | |
| Abbott Laboratories | $264.47 | 2019 | |
| Amgen INC. | $248.75 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $211.75 | 2019 | |
| Cook Medical LLC | $122.31 | 2019-2020 | |
| Amarin Pharma, INC. | $72.86 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $53.47 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $53.35 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $48.28 | 2019 | |
| Abbvie INC. | $32.26 | 2022-2024 | |
| Angiodynamics, INC. | $19.41 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.29 | 2020 | |
| Bard Peripheral Vascular, INC. | $18.31 | 2020 | |
| Acist Medical Systems, INC. | $17.93 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $16.18 | 2019 | |
| Axonics, INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Rivers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.